Abstract：【Objective】To investigate the expression of human myeloid leukemia factor 1-interacting protein gene (MLF1IP) in patients with bladder urothelial carcinoma. 【Methods】A total of 52 patients with bladder urothelial carcinoma who underwent surgery in our hospital from February 2015 to February 2017 were selected. The resected cancer tissues and adjacent normal tissues were taken and divided into bladder urothelial carcinoma group (observation group) and adjacent group (control group). The expression levels of MLF1IP mRNA and MLF1IP in adjacent tissues and cancer tissues of all subjects were detected, the relationship between MLF1IP mRNA expression level and clinicopathological features of bladder urothelial carcinoma was analyzed, the effect of MLF1IP mRNA expression level on the prognosis of patients with bladder urothelial carcinoma was evaluated, and the related factors affecting the prognosis of patients with bladder urothelial carcinoma were analyzed. 【Results】The positive expression rate of MLF1IP, MLF1IP mRNA and MLF1IP level in the observation group were significantly higher than those in the control group (P<0.05). The expression of MLF1IP mRNA in patients with bladder urothelial carcinoma was related to the pathological grade and clinical stage of bladder urothelial carcinoma (P<0.05), but not to the patient's gender, age and tumor diameter (P>0.05). The 3-year overall survival rate of patients with high expression of MLF1IP mRNA was lower than that of patients with low expression of MLF1IP mRNA (P<0.05). The high expression of MLF1IP mRNA and pathological grade were independent risk factors affecting the prognosis of patients with bladder urothelial carcinoma (P<0.05). 【Conclusion】The high expression of MLF1IP in patients with bladder urothelial carcinoma is related to the pathological grade, clinical stage and prognosis. It is of great significance to evaluate the prognosis of patients.
张治国, 康文玉. MLF1IP在膀胱尿路上皮癌组织中的表达及其临床意义[J]. 医学临床研究, 2022, 39(3): 432-434.
ZHANG Zhi-guo, KANG Wen-yu. Expression of MLF1IP in Bladder Urothelial Carcinoma and its Clinical Significance. JOURNAL OF CLINICAL RESEARCH, 2022, 39(3): 432-434.
[1] 朱波, 曾琪, 潘广瑞, 等. 抗菌肽LL-37与膀胱尿路上皮癌关系的初步探讨[J].中国现代医学杂志, 2018, 28(7):36-40. [2] HUANG D P, LUO R C. MLF1IP is correlated with progression and prognosis in luminal breast cancer[J].Biochem Biophys Res Commun,2016, 477(4):923-926. [3] 曾欣欣, 毛先海, 吴一飞, 等. 慢病毒介导的RNA干扰沉默MLF1IP基在胆管癌RBE细胞中的表达[J].湖南师范大学学报(医学版), 2016, 13(2):16-19. [4] 何朝辉, 唐福才, 曹正国, 等. PIWIL2在膀胱尿路上皮癌组织中的表达及临床意义[J].现代泌尿生殖肿瘤杂志, 2018, 10(2):79-81. [5] YU C, LIU Z, CHEN Q,et al. Nkx2.8 inhibits epithelial-mesenchymal transition in bladder urothelial carcinoma via transcriptional repression of Twist1[J].Cancer Res,2018, 78(5):1241-1252. [6] 李勇, 徐志刚, 程文广. 尿道膀胱肿瘤电切术与绿激光治疗膀胱尿路上皮癌的疗效对比[J].河北医学, 2018, 24(9):1544-1548. [7] 楼煜清. 线粒体融合基因2(MFN2)调控肺腺癌细胞功能的机制研究[D]. 上海:上海交通大学,2017. [8] YANG F, WANG Y H, DONG S Y, et al. MLF1IP promotes cells proliferation and apoptosis by regulating CyclinD1 in breast cancer[J].Int J Clinexppathol,2017, 10(12):11554-11562. [9] FENG G, ZHANG T, LIU J, et al. MLF1IP promotes normal erythroid proliferation and is involved in the pathogenesis of polycythemia vera[J].Febs Lett,2017, 591(5):760-773. [10] 黄督平. MLF1IP在Luminal型乳腺癌中的表达及其对他莫昔芬敏感性的影响[D].广州:南方医科大学, 2017.
2022, Vol. 39 
